ClinicalTrials.gg
CompletedNCT02797106TOXSIALOUpdated Jun 13, 2016

Management of Drooling in Children With Cerebral Palsy in France

An observational study in Cerebral Palsy and Pathological Drooling, sponsored by Hospices Civils de Lyon. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-13.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Time perspective
Cross-sectional
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

The study is a transversal, observational, descriptive survey of the practices and opinions of health professionals carried out nationally across France that aims to characterize children with cerebral palsy and pathological drooling and to describe care pathways, assessment and treatment of drooling.

02

Conditions studied

  • Cerebral Palsy
  • Pathological Drooling

Keywords

  • Drooling
  • Cerebral palsy
  • Botulinium toxin
  • Practice survey of health professionals
  • Children
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's enrollment of 400 is above the median of 63 across 472 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

health care professionals potentially involved in assessment and/or treatment of drooling in children with Cerebral Palsy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • health professional known to assess and/or treat drooling
  • health professional known to assess and/or treat children with Cerebral Palsy
  • health professional exercising in France

Exclusion criteria

Exclusion Criteria:

  • health professional with an inactive e-mail address
05

Study design

Time perspective
Cross-sectional
Enrollment
400 participants (actual)
Patient registry
No

Groups and cohorts

  • health care professionals

    health care professionals potentially involved in assessment and/or treatment of drooling in children with Cerebral Palsy.

    Other: Practice survey of health professionals

Interventions

  • OtherPractice survey of health professionals

    Survey of the practices and opinions of health care professionals to describe care pathways, assessment and treatment of drooling in children with cerebral palsy

06

What researchers measure

Primary outcomes

  1. Questionnaire on the assessment and treatment of drooling in children with Cerebral Palsy

    Questionnaire will measure practices of health professionals involved in care pathways, assessment and treatment of drooling in children with Cerebral Palsy.

    Time frame: Day 1 (At the time of the questionnaire mailing to the professionals)

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2013, a primary completion of Apr 2014 and a completion of Apr 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 31, 2016
First posted
Jun 13, 2016
Start
Apr 2013
Primary completionActual
Apr 2014
CompletionActual
Apr 2014
Last update
Jun 13, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02797106
Responsible party
Sponsor
First posted
Jun 13, 2016
Start date
Apr 2013
Primary completion
Apr 2014
Completion
Apr 2014
Last update
Jun 13, 2016

Study contacts

Emmanuelle CHALEAT-VALAYER, MD
principal investigator · CMCR des Massues -Croix Rouge Française, Lyon

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion